University of Helsinki quantifies immune cell infiltration in hantavirus kidney biopsies using AI
“University of Helsinki quantifies immune cell infiltration in hantavirus kidney biopsies using AI” documents a Diagnostics & Pathology deployment in Pharmaceutical & Life Science at University of Helsinki. www.aiforia.com reports training annotations required: ~500; this directory has not independently verified that result.
Evidence at a glance
- Evidence status:
- Automated evidence gate passed
- Deployment timeframe:
- Not reported by source
- Reported outcome metrics:
- 2 cited below
- Directory entry published:
- Source link checked:
The source-link check confirms reachability, not independent re-verification of every claim.
Source-reported figures — cited source: www.aiforia.com
The Challenge
Researchers studying puumalavirus-infected patients with acute hemorrhagic fever with renal syndrome (HFRS) needed to quantify specific immune cell markers (HLA-DR, CD14, CD16, CD68) in kidney biopsy specimens. Manual microscopy-based cell counting across stained slides was labor-intensive and prone to variability.
The Solution
The team deployed Aiforia's deep learning AI platform to automate quantification of monocyte and macrophage markers relative to total cell counts in scanned kidney biopsy specimens. The AI model was trained over approximately 2,500 iterations based on around 500 annotations.
Results
The AI-assisted analysis revealed increased numbers of cells expressing monocyte and macrophage markers in the kidneys of HFRS patients compared to controls, contributing to two peer-reviewed publications in PLOS Pathogens (2021). The approach enabled scalable, consistent quantification across large slide sets.
Key Takeaways
- Deep learning AI can automate tedious cell quantification tasks in infectious disease pathology research with relatively modest annotation effort (~500 annotations).
- AI-assisted image analysis enables reproducible quantification of immune infiltrates, reducing inter-observer variability in research studies.
- Academic pathology labs can leverage commercial AI platforms to accelerate publication-quality research without building custom tools.
Explore Related
Details
- Industry
- Pharmaceutical & Life Science
- Use Case
- Diagnostics & Pathology
- AI Technology
- Computer Vision & Medical Imaging
- Company Size
- Enterprise
- Company
- University of Helsinki
- Evidence status
- Automated evidence gate passed
- Deployment timeframe
- Not reported by source
- Directory entry published
- Source link checked
Cited source
www.aiforia.comHave a similar implementation?
Share your customer's AI results and link it to your vendor profile.
Submit a case study →